Redmile Group, LLC Catalent, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 595,570 shares of CTLT stock, worth $35.7 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
595,570
Previous 632,464
5.83%
Holding current value
$35.7 Million
Previous $35.7 Million
6.2%
% of portfolio
2.18%
Previous 1.41%
Shares
17 transactions
Others Institutions Holding CTLT
# of Institutions
489Shares Held
165MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$921 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$660 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$440 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$298 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.8B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...